Dr. Christoph Spinner is an infectiologist and pandemic officer at the Klinikum rechts der Isar university hospital of the Technical University of Munich. Image: argum, MRI |
The new form of treatment has proven highly effective against severe Covid-19 illness above all in persons with chronic conditions who do not respond sufficiently to an active vaccination.
“With approval by the European Medicines Agency (EMA) on November 12, the neutralizing antibodies can now be widely used at an early stage of the illness,” said adjunct teaching professor Dr. Christoph Spinner, infectious disease specialist and pandemic officer at Klinikum rechts der Isar, and his colleague, adjunct teaching professor Dr. Jochen Schneider, who heads the new Covid-19 outpatient clinic for monoclonal antibody treatment at the same hospital.
With the current surge in patient numbers, especially in Bavaria, the experts believe that this treatment can benefit many people and should therefore be made widely available as quickly as possible.
“To make that happen, we will be happy to share our skills and experience from a university clinic with colleagues at other hospitals in the fight against the pandemic,” says Dr. Spinner.